GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaNutra SpA (MIL:PHN) » Definitions » Forward PE Ratio

PharmaNutra SpA (MIL:PHN) Forward PE Ratio : 23.90 (As of Dec. 14, 2024)


View and export this data going back to 2017. Start your Free Trial

What is PharmaNutra SpA Forward PE Ratio?

PharmaNutra SpA's Forward PE Ratio for today is 23.90.

PharmaNutra SpA's PE Ratio without NRI for today is 32.61.

PharmaNutra SpA's PE Ratio (TTM) for today is 32.40.


PharmaNutra SpA Forward PE Ratio Historical Data

The historical data trend for PharmaNutra SpA's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaNutra SpA Forward PE Ratio Chart

PharmaNutra SpA Annual Data
Trend 2024-12
Forward PE Ratio
24.48

PharmaNutra SpA Quarterly Data
2024-12
Forward PE Ratio 24.48

Competitive Comparison of PharmaNutra SpA's Forward PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaNutra SpA's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaNutra SpA's Forward PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaNutra SpA's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where PharmaNutra SpA's Forward PE Ratio falls into.



PharmaNutra SpA Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


PharmaNutra SpA  (MIL:PHN) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


PharmaNutra SpA Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of PharmaNutra SpA's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaNutra SpA Business Description

Traded in Other Exchanges
Address
Via Campodavela 1, Pisa, ITA, 56122
PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, Asia, and others.

PharmaNutra SpA Headlines

No Headlines